| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 43 |
| 1 | PREDNISONE | 19 |
| 2 | FOLIC ACID | 18 |
| 3 | METHOTREXATE SODIUM | 17 |
| 4 | METHOTREXATE | 15 |
| 5 | CARBIDOPA AND LEVODOPA | 14 |
| 6 | METFORMIN | 14 |
| 7 | METRONIDAZOLE | 14 |
| 8 | TOFACITINIB | 14 |
| 9 | USTEKINUMAB | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MANGANESE CHLORIDE | 1 | 0.0036 |
| 1 | TOLCAPONE | 1 | 0.0028 |
| 2 | LEVOLEUCOVORIN INJECTION | 5 | 0.0016 |
| 3 | LEVOLEUCOVORIN | 5 | 0.0013 |
| 4 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 5 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 1 | 0.0011 |
| 6 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 7 | LURBINECTEDIN | 1 | 0.0009 |
| 8 | LOPERAMIDE HCL | 11 | 0.0008 |
| 9 | POTASSIUM IODIDE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 24 |
| 1 | Interleukin-23 Antagonist [EPC] | 21 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 4 | Vitamin B12 [EPC] | 20 |
| 5 | Vitamin C [EPC] | 19 |
| 6 | Vitamin D [EPC] | 18 |
| 7 | Aromatic Amino Acid [EPC] | 15 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 15 |
| 9 | Janus Kinase Inhibitor [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 2 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 3 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |
| 4 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 5 | Nonergot Dopamine Agonist [EPC] | 4 | 0.0003 |
| 6 | Aromatic Amino Acid [EPC] | 15 | 0.0002 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 11 | 0.0002 |
| 8 | GLP-2 Analog [EPC] | 3 | 0.0002 |
| 9 | Interleukin-17A Antagonist [EPC] | 8 | 0.0002 |